Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • IBM vs GSK✓SelectedUSD · GSKIBM vs GSK performance historyLatest closeAs of-2.03%11/19
Stock and ETF performance explorer

IBM vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-20.3%
GSK return
+5.3%
Excess return
-25.6%
Maximum drawdown
-37.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.0%-1.6%-0.5%-1.7%
7D-8.5%-4.7%-3.8%-7.4%
30D-6.8%-4.7%-2.1%-5.8%
3M-4.9%-8.8%+3.8%-2.9%
6M+2.1%-4.6%+6.7%+4.0%
YTD-22.3%+1.0%-23.3%-23.0%
1Y-20.3%+6.9%-27.2%-21.3%
All-20.3%+5.3%-25.6%-21.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling